Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemopreventive effects of 5-ASA and UDCA in ulcerative colitis
2009-010921-38Phase 2Active
- Sponsor
- University Medical Center Utrecht
- Start
- Mar 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of Salcrozine and ursodeoxycholic acid in autoimmune colitis and colorectal cancer (CRC), sponsored by University Medical Center Utrecht. Primary endpoint: Change in aberrant crypt foci (ACF) number. Started Mar 2009; status: active.
02
Drugs
Salcrozineursodeoxycholic acid
03
Conditions
autoimmune colitiscolorectal cancer (CRC)
Beyond the preview
Go deeper on 2009-010921-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010921-38.